Trademark Overview
On Thursday, March 21, 2024, a trademark application was filed for AGN1 with the United States Patent and Trademark Office. The USPTO has given the AGN1 trademark a serial number of 98461614. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, February 6, 2025. This trademark is owned by AgNovos Healthcare USA, LLC. The AGN1 trademark is filed in the Pharmaceutical Products category with the following description:
Bone void fillers consisting of biological materials; pharmaceutical products for treatment of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for altering bone density; medications for the prevention or treatment of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for preventing or treating of osteoporosis, osteopenia, osteoarthritis, osteotraumatic injuries, degenerative bone diseases and joint diseases; pharmaceutical preparations for use in enhancing cardiovascular health and bone health